Improved pyrexia-related outcomes associated with an adapted pyrexia adverse event management algorithm in patients treated with adjuvant dabrafenib plus trametinib: Primary results of COMBI-APlus
Victoria Atkinson, Caroline Robert, Jean‐Jacques Grob, Helen Gogas, Caroline Dutriaux, Lev Demidov, Avinash Gupta, Alexander M. Menzies, Bettina Ryll, Flora Miranda, Hiya Banerjee, Mike Lau, Michele Del Vecchio
Topics & Concepts
MedicineDabrafenibTrametinibDiscontinuationAdverse effectClinical endpointInternal medicineConfidence intervalSurgeryGastroenterologyRandomized controlled trialCancerMetastatic melanomaVemurafenibCell biologyBiologyMAPK/ERK pathwayKinaseMelanoma and MAPK PathwaysCutaneous Melanoma Detection and ManagementLung Cancer Treatments and Mutations